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APOBEC3 Host Factors Modulate Viral Production and Infectivity of HIV-2
Several studies indicate that susceptibility to host factors could explain pathogenic differences between
HIV-2 and HIV-1. Deaminases of APOBEC3 (A3) family, particularly A3G, have antiviral activity
against HIV-1 which is suppressed by the viral protein Vif. Little is known concerning HIV-2 inhibition
by the different members of the APOBEC3 family.
Probably HIV-2 and HIV-1 have differences in the threshold requirements for the same cellular factor or
in the involvement of different factors to compensate for Vif1 and Vif2 functions2,3 considering that :
- Vif2 and Vif1 share only 30% of identity
- Vif2-induced degradation of A3 proteins is different from the one previously observed by Vif1.1
- HIV-2 and HIV-1 vif defective viruses produced in different T-cell lines showed differential
replication and capacity for productive infection
Review and Aims
Our aim is to characterize the effect of several A3 proteins in HIV-2 production and infectivity, in order to
understand the differences between HIV-1 and HIV-2 and to characterize specific determinants of HIV-2
pathogenesis.
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Methods
STEP1: Several A3 genes were cloned in the same expression vector system, expressing A3 in fusion
with 3 HA-tags in C-terminal, using PCR ligation strategy :
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Methods
STEP 2: Viral production in HEK293T cells, protein detection in cell lysates and infection of TZM-bl
cells with HIV-2 and HIV-1 wild type (wt) and Vif defective (Vif-) virions, produced in the absence or
presence of different A3 proteins.
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Results
Viral production of HIV-1 is higher than HIV-2 production in 293T cells transfected with the same 
amount of DNA. 
Infectivity detection system used has a higher discriminatory power for HIV-1 infections.
Fig. 1 Differences in production levels of HIV-2 and HIV-1. A), B) 293T cells were transfected with HIVWT and HIV Vif- molecular
clones, in the presence or absence of several A3 expression vectors in ratio of 1:1 HIV:A3 (1µg of each DNA). Supernatant viral RNA
levels was determined by RT-PCR in Virology Laboratory of Egas Moniz Hospital using specific primers for LTR region of HIV-2 and
ENV region of HIV-1. Results from one representative assay. C) TZM-bl infectivity values using different dilutions of HIV-2 and HIV-
1WT
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Results
Viral production is affected by the presence of A3 proteins and by the efficiency of transfection.
In the presence of A3 proteins, HIV-2Vif- production decreases drastically. 
Fig. 2 A3 proteins inhibit viral production of HIV-2 (A) and HIV-2 vif-(B) . pRL.CMV (Renilla expression vector) it was used as a
transfection efficiency control of 293T producing cells . Values  of Renilla activity are presented as n fold in relation to cell background
(secondary axis). Produced viral levels (copies/mL) were normalized with values of transfection efficiency control determined in the
producing cell lysates for each condition.
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Results
Fig. A3 proteins inhibit viral production of HIV-1 (C) and HIV-1 vif- (D) pRL.CMV (Renilla expression vector) it was used as a
transfection efficiency control of 293T producing cells . Values  of Renilla activity are presented as n fold in relation to cell background
(secondary axis). Produced viral levels (cop/mL) were normalized with values of transfection efficiency control determined in the
producing cell lysates for each condition. Porque mudou o tipo de letra?
Viral production is affected by the presence of A3 proteins and by the efficiency of transfection.
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Results
A3B and A3G inhibit HIV-2 Vif- infectivity
and they are strongly neutralized by Vif2.
Fig. 3 A) Viral infectivity of HIV-2wt and HIV-2Vif- produced in the presence of different APOBEC. After virus normalization, A3
antiviral effects were evaluated by one cycle infectivity assay in TZM-bl cells. Values  are presented as % of infectivity relative to viruses
produced in the absence of A3, defined as 100% (empty vector was used as control). Columns and error bars represent average ± SD,
respectively (n=2); B) Sensitivity of A3 proteins to Vif2. Representative Western blot of A3 proteins in virus-producing cells lysates.
Vif2-induced degradation of A3B and A3G
in producing cells lysates
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Conclusions
 In transfected 293T cells HIV-1production is higher than HIV-2 production.
 Viral production is affected by the presence of A3 and by the efficiency of transfection.
 This effect is more pronounced in HIV-2Vif- productions.
 HIV-2 infectivity is strongly inhibited by A3B and A3G and this antiviral effect is efficiently
suppressed by Vif2 protein.
In the near future, we will compare HIV-2 and HIV-1 infectivity using viral stocks produced in the
presence of lower amounts of A3, to avoid the effect on viral production.
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